STOCK TITAN

John C. Malone gains majority voting power at Atlanta Braves Holdings (BATRA)

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Atlanta Braves Holdings, Inc. investor John C. Malone has updated his ownership, reporting beneficial control of about 50.01% of the company’s voting power in director elections through Series A and high‑vote Series B common stock.

He directly and indirectly holds 557,039 shares of Series A Common Stock, or about 5.4% of that class, and 949,201 shares of Series B Common Stock, or about 97.1% of that class, based on the share counts outstanding as of October 31, 2025. Recent purchases include multiple open‑market buys of Series A between $41.96 and $44.74 per share and a privately negotiated Series B purchase at $48.17 per share.

Because Malone now beneficially holds more than a majority of the outstanding voting securities, Atlanta Braves Holdings will be deemed a “Controlled Company” under Nasdaq rules, giving him significant influence over the board, major transactions and other matters requiring shareholder approval, subject to Major League Baseball rules and existing voting agreements.

Positive

  • None.

Negative

  • None.

Insights

John C. Malone now holds effective voting control of Atlanta Braves Holdings, reshaping its governance profile without announcing specific strategic changes.

John C. Malone reports beneficial ownership of voting equity representing about 50.01% of the voting power in director elections. This comes from 557,039 Series A shares (about 5.4% of that class) and 949,201 Series B shares (about 97.1% of Series B), based on outstanding shares as of October 31, 2025.

The filing notes that, as a result, Atlanta Braves Holdings will be treated as a “Controlled Company” under Nasdaq Rule 5615. Malone indicates he may buy more or sell shares over time but currently lists no concrete plans for mergers, asset sales, or changes to capitalization beyond what is described.

Recent activity includes open‑market purchases of Series A stock on November 18–19, 2025 at prices around $41.99–$42.00 per share, a privately negotiated Series B purchase at $48.17 on February 4, 2026, and additional Series A buys on February 5, 2026 at a volume‑weighted average price of $44.23. Subsequent company filings may clarify how Controlled Company status is used in board and committee structures.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Row 7: John C. Malone ("Mr. Malone") together with Terence F. McGuirk ("Mr. McGuirk") may be deemed to constitute a "group" within the meaning of Section 13(d) of the Act on account of the Malone Voting Agreement and the Malone LLC Operating Agreement. Mr. Malone expressly disclaims membership in such a group. Note to Rows 7, 9, and 11: Includes 10,177 shares of Atlanta Braves Holdings, Inc.'s (the "Issuer") Series A common stock, par value $0.01 per share (the "Series A Common Stock") held in a revocable trust (the "LM Revocable Trust") with respect to which Mr. Malone and Mr. Malone's wife, Mrs. Leslie Malone ("Mrs. Malone"), are trustees. Mrs. Malone has the right to revoke such trust at any time. Mr. Malone disclaims beneficial ownership of the shares held by the LM Revocable Trust. Note to Rows 7, 9, and 11: Does not include shares of Series A Common Stock issuable upon conversion of shares of the Issuer's Series B Common Stock, par value $0.01 per share (the "Series B Common Stock") beneficially owned by Mr. Malone; however, if such shares of Series A Common Stock were included, Mr. Malone would have beneficial ownership of 1,506,240 shares of Series A Common Stock and Mr. Malone's beneficial ownership of Series A Common Stock would be 13.4% of the outstanding shares of Series A Common Stock. Note to Rows 7, 9, and 11: Includes 25,000 shares of Series A Common Stock held by the Malone Family Land Preservation Foundation, as to which shares Mr. Malone disclaims beneficial ownership. Note to Rows 7, 9, and 11: Includes 521,862 shares of Series A Common Stock held in a revocable trust (the "JM Revocable Trust") with respect to which Mr. Malone is trustee. Mr. Malone has the right to revoke such trust at any time. Note to Row 13: Calculated based upon the 10,318,187 shares of Series A Common Stock as of October 31, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Securities and Exchange Commission on November 5, 2025. At the option of the holder, each share of Series B Common Stock is convertible into one share of Series A Common Stock. Each share of Series B Common Stock is entitled to 10 votes, whereas each share of Series A Common Stock is entitled to one vote. Accordingly, Mr. Malone may be deemed to beneficially own voting equity securities of the Issuer representing approximately 50.01% of the voting power with respect to a general election of directors of the Issuer, calculated based on 10,318,187 shares of Series A Common Stock and 977,751 shares of Series B Common Stock outstanding as of October 31, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Securities and Exchange Commission on November 5, 2025. See Item 5. This Amendment No. 5 to the Schedule 13D relates to two series of Common Stock, the Series A Common Stock and the Series B Common Stock. Due to technical limitations of only being able to enter nine alpha numeric characters on the facing sheet of this Amendment No. 5, we are filing two versions of this Amendment No. 5 that amend the same Schedule 13D. The first relates to the Series A Common Stock (CUSIP: 047726104). The second relates to the Series B Common Stock (CUSIP: 047726203).


SCHEDULE 13D


John C. Malone
Signature:/s/ John C. Malone
Name/Title:John C. Malone
Date:02/09/2026

FAQ

What does John C. Malone’s latest Schedule 13D/A say about his ownership in Atlanta Braves Holdings (BATRA)?

John C. Malone now beneficially controls about 50.01% of Atlanta Braves Holdings’ voting power. He holds 557,039 Series A shares and 949,201 Series B shares, giving him majority voting control in director elections while still owning a relatively small portion of the lower‑vote Series A class.

How many Atlanta Braves Holdings (BATRA) shares does John C. Malone beneficially own by class?

Malone reports 557,039 Series A and 949,201 Series B shares beneficially owned. The filing states this equals roughly 5.4% of outstanding Series A and 97.1% of outstanding Series B, calculated using share counts reported by the company as of October 31, 2025.

What recent share purchases in BATRA does John C. Malone disclose in this Schedule 13D/A amendment?

Malone reports several late‑2025 and early‑2026 purchases of Atlanta Braves Holdings stock. He bought 6,890 Series A shares in November 2025 around $42 per share, 3,669 Series B shares privately at $48.17 on February 4, 2026, and 35,000 Series A shares on February 5, 2026 at a $44.23 average.

What does it mean that Atlanta Braves Holdings (BATRA) is now a “Controlled Company” under Nasdaq rules?

The filing states Atlanta Braves Holdings will be deemed a “Controlled Company.” Because Malone beneficially holds more than a majority of the outstanding voting securities, Nasdaq Rule 5615 treats the company as controlled, which can affect board independence requirements and governance practices, subject to applicable league and agreement constraints.

How does Atlanta Braves Holdings’ dual‑class structure affect John C. Malone’s control over BATRA?

Malone’s control stems largely from high‑vote Series B shares. Each Series B share carries 10 votes versus one vote for Series A, and he beneficially owns about 97.1% of Series B. This structure gives him approximately 50.01% voting power despite a smaller economic stake in Series A shares.

Does John C. Malone disclose any specific plans for Atlanta Braves Holdings (BATRA) after gaining majority voting power?

Malone reports no specific immediate plans for major corporate changes. He notes he may buy or sell shares in the future but lists no current plans for mergers, asset sales, board changes, or other significant transactions beyond what is already described and a referenced prior Form 8‑K.
Atlanta Braves Holdings, Inc

NASDAQ:BATRA

BATRA Rankings

BATRA Latest News

BATRA Latest SEC Filings

BATRA Stock Data

2.73B
55.63M
5.41%
76.4%
0.49%
Entertainment
Services-amusement & Recreation Services
Link
United States
ATLANTA